Discovery Services

Overview
Pre-clinical custom peptides and oligos
Custom Peptide Synthesis
Peptide modifications for discovery research
Custom Oligo Synthesis
ASO, siRNA, miRNA, PMO, aptamer, CpG, decoy
Conjugate Synthesis
Peptide, small-molecule, oligo conjugates (e.g., POCs, PPMOs)
FTE Services
Full-Time Equivalent (FTE) Model

CDMO Services

OverviewGMP Manufacturing CDMO Services
GMP PeptidesNCE Development & CMC Peptide Manufacturing
Oligonucleotide NCEs NEW VIDEOCMC development for oligo therapeutics
Generic APIsGeneric peptide, oligo, and small molecule offerings
Formulation Services NEW VIDEOFinished Dosage Form (FDF) Formulation Services

Quotation Request

Overview
Request for a peptide or oligo quotation
Research Peptide Quote
Quotation request for custom research-grade peptides
GMP Peptide Quote
GMP peptide manufacturing project proposal
Oligonucleotide Quote
Quotation request for GMP- and non-GMP-grade oligos
⚠️ Official Notice: www.sinopep.com is the only official Sinopep site. We work with qualified research and pharmaceutical organizations only. No consumer sales.
Learn More

  • Follow
  • Follow
  • Follow
  • Company Overview
  • Press Releases
  • Events
  • Careers
  • Login
Peptide CDMO Sinopep Logo
  • CDMO Services
    • Discovery
    • Peptide NCEs
    • Oligonucleotide NCEs
    • Generic APIs
    • Formulation
  • Discovery Services
    • Peptide Synthesis
    • Oligo Synthesis
    • Conjugates
    • FTE Services
  • Manufacturing
    • Regulatory Affairs
    • Quality
    • Capacity
  • Quotation
  • GMP Request
  • Knowledge Center
    • Publications
    • Whitepapers
    • Frequently Asked Questions
  • About
    • About Us
    • Press Releases
    • News
    • Events
    • Videos
    • Locations
    • Careers
    • Contact Us
Peptide CDMO Sinopep Logo
  • Services
  • Manufacturing
    • GMP Peptide Service Request
    • Capacity
    • Quality
    • Regulatory Affairs
    • Sustainability
  • Knowledge
    • Knowledge Center
    • Frequently Asked Questions
    • Brochures
    • Publications
    • Whitepaper NEW
    • Videos
    • Tour Previews
  • About
    • About Us
    • Press Releases
    • News
    • Events
    • Locations
    • Videos
    • Careers
    • Media Library
    • Contact Us
  • Contact Us

Category: Press Releases

  • Brochures
  • Citations
  • Flyer
  • Insights from Sinopep
  • Past Events
  • Press Releases
  • Publications
  • Sustainability
  • Videos
  • Whitepaper
Sinopep sustainability EcoVadis silver medal award

ApexTide Site in Hangzhou (Xiasha) Earns EcoVadis Silver Rating

Nov 11, 2025 | Press Releases, Sustainability

read more...
Sinopep EcoVadis sustainability rating

Sinopep’s Lianyungang Site Earns EcoVadis Bronze Medal Certification

Sep 16, 2025 | Press Releases, Sustainability

read more...
Certificate of Good Manufacturing Practices (CBPF-GMP) from ANVISA

Sinopep’s Lianyungang Facility Achieves Brazilian Health Regulatory Agency (ANVISA) GMP Certification

Aug 7, 2025 | Press Releases

read more...
RP-HPLC Column Purification GMP Peptides

Bio-Synthesis: Forging New Quality Productive Forces | Strategic Cooperation Between Sinopep and Vazyme

Jun 20, 2025 | Press Releases

read more...
Apextide 𝗗𝗠𝗙 𝗳𝗼𝗿 𝗶𝗻𝗰𝗹𝗶𝘀𝗶𝗿𝗮𝗻 𝗔𝗣𝗜

Apextide received acknowledgment from the U.S. FDA for submission of a DMF for inclisiran API.

Apr 18, 2025 | Press Releases

read more...
Apextide 𝗗𝗠𝗙 𝗳𝗼𝗿 𝗶𝗻𝗰𝗹𝗶𝘀𝗶𝗿𝗮𝗻 𝗔𝗣𝗜

Apextide successfully completed the GMP inspection by the FDA

Mar 6, 2025 | Press Releases

read more...
GMP large-scale peptide production facility—Workshop 601— Lianyungang factory

The official launch of Sinopep’s fourth-generation large-scale peptide production facility—Workshop 601—at its Lianyungang factory

Jan 14, 2025 | Press Releases

read more...
227a978c3fe91a4c6f82d6bd6d012e9a.png The signing ceremony took place at SINOPEP’s headquarters in Hangzhou, with Ziquan Tong, Chairman of SINOPEP, and Mr. Keith Cronce, Chief Operating Officer of Fluid Air, representing both companies.

Strategic Cooperation Between SINOPEP and Spraying Systems Co.

Dec 10, 2024 | Press Releases

read more...
FDA Inspection at Sinopep for GMP Manufacturing

Sinopep has obtained FDA First Adequate Letter for Semaglutide

Dec 18, 2023 | Press Releases

read more...
FDA Inspection at Sinopep for GMP Manufacturing

Sinopep Receives FDA First Adequate Letter for Liraglutide

Oct 13, 2023 | Press Releases

read more...
« Older Entries
Sinopep Peptide and Oligo CDMO

Sinopep is a trusted CDMO specializing in end-to-end CMC development and cGMP manufacturing of peptide and oligonucleotide APIs for NCEs, from early-phase development to commercialization.

  • Follow
  • Follow
  • Follow
Quick Links
About Us
Quotation Request
News
Events
Locations
Contact Us
CDMO Services
Peptides
Oligonucleotides
Capacity
Quality
Formulation
Regulatory Affairs
Contact Us


No. 1378 Wenyi West Road, Yuhang District, Hangzhou City, Zhejiang 311121, China



+001 949-892-7190
(USA BD Team)



tides@sinopep.com

© 2026 Sinopep-Allsino Biopharmaceutical Co., Ltd. All rights reserved.  |  Privacy Policy  |  Cookie Policy  |  Manage Cookie Preferences

Sinopep-Allsino Biopharmaceutical Co., Ltd.
Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}